Showing 771-780 of 974 results for "".
- NIH Selects Dr. Michael Chiang as Director of the National Eye Institutehttps://modernod.com/news/nih-selects-dr-michael-chiang-as-director-of-the-national-eye-institute/2478074/National Institutes of Health Director Francis S. Collins, MD, PhD, has chosen Michael F. Chiang, MD, as director of NIH’s National Eye Institute (NEI). A practicing ophthalmologist, Dr. Chiang is currently the Knowles Professor of Ophthalmology & Medical Informatics and Clinical Epide
- Insight Into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracyhttps://modernod.com/news/insight-into-fdas-revised-policy-on-antibody-tests-prioritizing-access-and-accuracy/2477725/In a blog post on the FDA website, agency leaders outlined a new policy that aims to provide more oversight of COVID-19 antibody tests. The revised policy on antibody tests was written by Anand Shah, MD, Deputy Commissioner for Medical and Scientific Affairs, and Jeff Shuren, MD, Director,
- Experts Provide Advice on How to Handle Staff and Ensure Business Survival When the Practice Closeshttps://modernod.com/news/ootg-webcast-experts-provide-advice-on-how-to-handle-staff-and-ensure-business-survival-when-the-practice-closes/2477517/In the latest episode of Ophthalmology off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, touched base with practice management experts Bruce Maller and Matt Jensen who shed light on key areas of concern for practice leaders. Mr. Maller and Mr. Jensen provide insight on a variet
- Oculis Announces Appointment of Leading Ophthalmology Specialists to Scientific Advisory Boardhttps://modernod.com/news/oculis-announces-appointment-of-leading-ophthalmology-specialists-to-scientific-advisory-board/2476888/Oculis SA announced the appointments of Eric Donnenfeld, MD, and Pr. Ramin Tadayoni, MD, PhD, to its Scientific Advisory Board (SAB). “I am pleased to welcome Eric and Ramin to our SAB and look forward to their contributions as we focus on our objective of developing topical medicines that
- National Cancer Institute Director Ned Sharpless to Become Acting FDA Headhttps://modernod.com/news/national-cancer-institute-director-ned-sharpless-to-cecome-acting-fda-head/2476373/Ned Sharpless, MD, the current director of the US National Cancer Institute (NCI), will assume the position of acting chief of the FDA when Scott Gottlieb, MD, steps down next month. Dr. Gottlieb, who recently tendered his resignation from the role, is said to have recommended Dr. Sharpless for t
- The ASCRS Announces 2019 Ophthalmology Hall of Fame Inducteeshttps://modernod.com/news/the-ascrs-announces-2019-ophthalmology-hall-of-fame-inductees/2476313/The American Society of Cataract and Refractive Surgery (ASCRS) has announced that it will induct Howard V. Gimbel, MD, MPH, FRCSC, FACS and the late Phillips Thygeson, MD into the ASCRS Ophthalmology Hall of Fame on Saturday, May 4, 2019, according to a
- Statement From FDA Leadership On a Record Year for Device Innovationhttps://modernod.com/news/statement-from-fda-leadership-on-a-record-year-for-device-innovation/2479598/FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director for the Center for Devices and Radiological Health, released the following statement addressing a record year for device innovation: “The FDA’s focus on both safety and innovation stems from our historic mission
- Spark Therapeutics Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Awardhttps://modernod.com/news/spark-therapeutics-gene-therapy-pioneers-win-1-million-sanford-lorraine-cross-award/2476159/Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award. Jean Bennett, MD, PhD, and Katherine A. High, MD, whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on December 4 at Sanford He
- Bio-Tissue Highlights Publication of DREAM Studyhttps://modernod.com/news/bio-tissue-highlights-publication-of-dream-study/2480079/Bio-Tissue highlighted the publication of the Dry Eye Amniotic Membrane (DREAM) study in Clinical Ophthalmology.[1] This retrospective study was conducted at 10 clinical sites in the United States, led by Marguerite McDonald, MD, and Hosam Sheha, MD. It demonstrates that a single applica
- Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in MGDhttps://modernod.com/news/azura-ophthalmics-presents-positive-results-from-phase-2b-clinical-trial-of-azr-md-001-in-meibomian-gland-dysfunction/2481286/Azura Ophthalmics announced that positive 3-month efficacy and safety results from its